Response Genetics Q2 revenues up 24%

Response Genetics (NASDAQ:RGDX) Q2 results: Revenues: $5.3M (+24.1%); Operating Expenses: $3.9M (-19.2%); Operating Loss: ($1.3M) (+59.0%); Net Loss: ($1.3M) (+58.7%); Loss Per Share: ($0.04) (+50.0%); Quick Assets: $8.1M (+281.4%).

No financial guidance given.

Comments (1)
  • figaro75
    , contributor
    Comments (61) | Send Message
    Nice going guys! And here I thought you actually had good management! What garbage!
    14 Aug 2014, 12:37 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs